Adjuvant sequential dose-dense doxorubicin, paclitaxel, and cyclophosphamide (ATC) for high-risk breast cancer is feasible in the community setting.

Download in:

• JSON
• RDF
• N3/Turtle
• N-Triples

View as

• Triples